Gross Margin

Revolve Group boasts a stellar quarter with soaring sales and customer growth, but a one-time tariff refund artificially inflates profits, masking rising costs and negative cash flow.

DDC Enterprise reports a 28% revenue surge, but the real story is how its food business funds an ambitious Bitcoin treasury and shareholder value strategy.

Amid a truck market slump, Core Molding Technologies reveals a strategic shift, leveraging new ventures in energy storage and a major expansion in Mexico.

Shoals Technologies posts a 47% revenue surge and a record $801M backlog, yet shrinking profits reveal the immense operational friction of wiring the energy transition.

Ichor Holdings posts impressive Q2 growth, signaling a wider industry rebound. A $200M capital raise and disciplined strategy position it for the next tech supercycle.

A securities fraud lawsuit hits battery maker Microvast, alleging a pattern of false statements. We dissect the short-seller report, CFO exit, and missed targets.

QHSLab flips to Q2 profit, driven by a recurring revenue model that's reshaping primary care. Is its strategic debt cleanup the key to sustainable growth?

Autolus Therapeutics reports a 100% year-over-year sales jump and a stunning gross margin reversal, securing a $250M credit facility to fund its next big move.

As DarioHealth prepares its Q2 results, investors are watching closely. Can its disciplined cost-cutting and AI-powered platform deliver on the promise of profitability?

A deep dive into RBC Bearings' stellar quarter reveals more than just sales growth. Record backlogs and soaring defense demand signal a new era of growth.

As Acorn Energy prepares for its Q2 earnings call, investors are focused on volatile revenue. But the real story is its quiet expansion into securing our vital infrastructure.

The AI firm used a strategic maneuver to avoid delisting, but does its pivot to enterprise AI signal a true recovery or just a temporary market fix?

Apple posted its strongest June quarter ever, but a cautious forecast and warnings of critical supply constraints sent its stock tumbling after hours.

As CapsoVision preps its Q2 report, investors look past the numbers to its AI-driven pipeline, a key test of its strategy to reshape GI diagnostics.

A massive tariff refund inflated Columbia's earnings, masking U.S. weakness while its new strategy to woo younger shoppers shows early promise.

Despite a slight dip in sales, First Solar's profits soared in Q2. A closer look reveals a masterclass in strategy, leveraging domestic manufacturing.

Spineway secures €1.5M in crucial financing amid rising losses, betting on its innovative ESP® disc and surgeon education to finally turn revenue into profit.

As Vuzix prepares its Q2 2026 earnings call, investors will look past the numbers to a bigger question: can its pivot to an OEM model unlock its AR potential?

Data I/O reports a 59% sequential sales jump, but a surprise delay in its full earnings to analyze a complex $9M investment introduces critical uncertainty.

As Dollar General preps its Q2 earnings, all eyes are on what its results will reveal about inflation, consumer shifts, and the health of the U.S. economy.